Supported by the Department of Health's National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital, London, United Kingdom, and UCL Institute of Ophthalmology, London, United Kingdom (CAE, PAK, DAS, AT). The views expressed in the publication are those of the author and not necessarily those of the Department of Health.
Disclosure: P.D. Bradley, None; D.A. Sim, Allergan (R); P.A. Keane, Allergan (R); J. Cardoso, None; R. Agrawal, None; A. Tufail, Heidelberg Engineering (S), Novartis (S), Optovue (S), Pfizer (S), GSK (S), Thrombogenics (S), Bayer (S), Allergan (S); C.A. Egan, Novartis (F, S)